Mithra Pharmaceuticals S.A. | |
Stock Exchange | Euronext Brussels |
EPS |
EUR0.4 |
Market Cap |
EUR940.72 M |
Shares Outstanding |
37.69 M |
Public Float |
13.89 M |
Address |
Rue Saint-Georges 5 Liege WA 4000 Belgium |
Employees | - |
Website | http://www.mithra.com |
Updated | 07/08/2019 |
Mithra Pharmaceuticals SA engages in the development, manufacture, and commercialization of proprietary and differentiated drugs and generic products dedicated to female healthcare. It specializes in the following domains of health for women: contraception and fertility, menopause and osteoporosis, gynecological infections, and cancers. The company was founded by Jean-Michel Foidart and François Fornieri on July 8, 1999 and is headquartered in Liège, Belgium. |